Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Markusic

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Plos One|August 5, 2009
Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicityAshley T Martino, Sushrusha Nayak, Brad E Hoffman, et al.
Blood|April 3, 2015
Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ TregMoanaro Biswas, Debalina Sarkar, Sandeep R P Kumar, et al.
Blood|April 9, 2011
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liverAshley T Martino, Masataka Suzuki, David M Markusic, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2014
<i>Ex Vivo</i> Expanded Autologous Polyclonal Regulatory T Cells Suppress Inhibitor Formation in HemophiliaDebalina Sarkar, Moanaro Biswas, Gongxian Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytesNiek P van Til, David M Markusic, Roos van der Rijt, et al.
Retrovirology|February 5, 2008
Alteration of viral lipid composition by expression of the phospholipid floppase ABCB4 reduces HIV vector infectivityNiek P van Til, Kirstin M Heutinck, Roos van der Rijt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 30, 2019
Type I IFN Sensing by cDCs and CD4<sup>+</sup> T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8<sup>+</sup> T CellsJamie L Shirley, Geoffrey D Keeler, Alexandra Sherman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2010
High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosinesDavid M Markusic, Roland W Herzog, George V Aslanidi, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2024
B cell focused transient immune suppression protocol for efficient AAV readministration to the liverJyoti Rana, Roland W Herzog, Maite Muñoz-Melero, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2021
Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassetteSandeep R P Kumar, Jun Xie, Shilang Hu, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Plos One|August 5, 2009
Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicityAshley T Martino, Sushrusha Nayak, Brad E Hoffman, et al.
Blood|April 3, 2015
Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ TregMoanaro Biswas, Debalina Sarkar, Sandeep R P Kumar, et al.
Blood|April 9, 2011
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liverAshley T Martino, Masataka Suzuki, David M Markusic, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2014
<i>Ex Vivo</i> Expanded Autologous Polyclonal Regulatory T Cells Suppress Inhibitor Formation in HemophiliaDebalina Sarkar, Moanaro Biswas, Gongxian Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytesNiek P van Til, David M Markusic, Roos van der Rijt, et al.
Retrovirology|February 5, 2008
Alteration of viral lipid composition by expression of the phospholipid floppase ABCB4 reduces HIV vector infectivityNiek P van Til, Kirstin M Heutinck, Roos van der Rijt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 30, 2019
Type I IFN Sensing by cDCs and CD4<sup>+</sup> T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8<sup>+</sup> T CellsJamie L Shirley, Geoffrey D Keeler, Alexandra Sherman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2010
High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosinesDavid M Markusic, Roland W Herzog, George V Aslanidi, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2024
B cell focused transient immune suppression protocol for efficient AAV readministration to the liverJyoti Rana, Roland W Herzog, Maite Muñoz-Melero, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2021
Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassetteSandeep R P Kumar, Jun Xie, Shilang Hu, et al.
Pageof 5